Echocardiographic Evidence of Clozapine-Induced Myocarditis With Pericardial Involvement in a Young Woman
Chinelo Onyilofor1, Bryce Wininger2, Eric Isselbacher1
1Department of Cardiovascular Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Background:
Myocarditis is a rare adverse effect of clozapine, often occurring within the first month of use.
Case Summary:
We present a case of an 18-year-old woman who developed recurrent somnolence, orthostatic hypotension, and elevated troponins days after starting a clozapine induction, while also on valproic acid. Transthoracic echocardiogram (TTE) revealed a reduced left ventricular ejection fraction and symmetric left ventricular wall thickening concerning for myocardial edema, as well as a pericardial effusion. Clozapine was promptly withdrawn, and the patient was started on colchicine. Follow-up TTE showed improved left ventricular ejection fraction and resolution of left ventricular wall thickening.
Discussion:
Clozapine-induced myocarditis presents with elevated troponins and inflammatory markers; however, myocardial involvement may not always be detectable by TTE. Medication withdrawal and supportive care are the cornerstone of initial treatment.
Take-Home Message:
This case highlights the significant effects that clozapine can have on the myocardium, especially with concurrent use of valproic acid.
More Related Videos
14:24Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
09:17High-Resolution Endocardial and Epicardial Optical Mapping in a Sheep Model of Stretch-Induced Atrial Fibrillation
Published on: July 29, 2011
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
